KR101544180B1 - Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains - Google Patents
Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains Download PDFInfo
- Publication number
- KR101544180B1 KR101544180B1 KR1020130138053A KR20130138053A KR101544180B1 KR 101544180 B1 KR101544180 B1 KR 101544180B1 KR 1020130138053 A KR1020130138053 A KR 1020130138053A KR 20130138053 A KR20130138053 A KR 20130138053A KR 101544180 B1 KR101544180 B1 KR 101544180B1
- Authority
- KR
- South Korea
- Prior art keywords
- soybean
- linoleic acid
- conjugated linoleic
- cla
- strains
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명에서는 공액리놀레산 생산성이 우수하고 내산성 및 내담즙산성이 우수한 신규 락토바실러스 플란타륨 S48 균주 및 P1201 균주와, 이들 균주를 이용하여 제조되는 생균제제 (probiotics) 및 공액리놀레산이 풍부한 식품이 제공된다.
본 발명의 신규한 락토바실러스 플란타륨 S48 균주 및 P1201 균주는 CLA 생산성이 우수하여 CLA이 증대된 식품이 제조에 사용될 수 있다. 또한 본 발명의 균주들은 내산성 및 내담즙산성을 가져서 생균제제로 활용성이 크다. 본 발명에 따른 균주 및 이의 배양물로 제조된 식품은 CLA의 함유량이 증대되어서, 체중감량, 콜레스테롤 저하, 고지혈증 개선 및 동맥경화 완화 등에 상승적인 효과를 발휘하는 기능성 식품으로 사용될 수 있다. In the present invention, new Lactobacillus plantai strain S48 and P1201 strains excellent in the productivity of conjugated linoleic acid and excellent in acid resistance and bile acid resistance are provided, and probiotics and conjugated linoleic acid-rich foods produced using these strains are provided .
The novel Lactobacillus plantarum S48 strain and P1201 strain of the present invention are excellent in CLA productivity and can be used for production of CLA-enhanced foods. In addition, the strains of the present invention have acid resistance and bile acid resistance, and thus are highly utilizable as probiotics. The strains according to the present invention and foods made from the cultures of the present invention can be used as functional foods that exhibit a synergistic effect on weight loss, cholesterol lowering, hyperlipidemia improvement, and atherosclerosis relief by increasing the content of CLA.
Description
본 발명은 공액리놀레산의 생산성이 우수한 신규 락토바실러스 플란타륨 균주 및 이를 이용하여 제조된 생균제제와 공액리놀레산이 증대된 식품에 관한 것이다. 더욱 상세하게는 공액리놀레산 생산성이 우수하고 내산성 및 내담즙산성이 우수한 신규 락토바실러스 플란타륨 S48 균주 및 P1201 균주와, 이들 균주를 이용하여 제조되는 생균제제(probiotics) 및 공액리놀레산이 증대된 식품에 관한 것이다.
The present invention relates to novel Lactobacillus plantarum strains having excellent productivity of conjugated linoleic acid, and to a food product in which a probiotic agent and a conjugated linoleic acid produced using the same are increased. More particularly, the present invention relates to a novel Lactobacillus plantaitus S48 strain and P1201 strain excellent in the productivity of conjugated linoleic acid and excellent in acid resistance and bile acid resistance, probiotics prepared using these strains and foods having increased conjugated linoleic acid .
현대인은 과다한 스트레스와 건강에 부정적인 환경에 노출되어 있고, 고 단백질, 고 콜레스테롤의 음식을 많이 접하게 되어서, 각종 성인병 질환이 급증하였다. 특히 비만에 따른 각종 대사증후군 질병인 당뇨, 고혈압, 고지혈증, 동맥경화 및 치매 등의 환자수가 매년 증가에 따른 의료비 지출이 증가하고 있어 사회적인 문제로 대두하고 있다.Modern people are exposed to excessive stress and negative environment of health, high protein and high cholesterol foods have been exposed to many foods and various diseases have increased rapidly. Especially, diabetes, hypertension, hyperlipidemia, atherosclerosis and dementia, which are various metabolic syndrome diseases caused by obesity, are increasing as a result of an increase in the annual expenditure of medical expenses.
공액리놀레산(Conjugated Linoleic Acid; CLA)은 리놀레산의 이성질체로 공액이중결합 구조를 가지는 것으로, 항암작용, 체지방감소 효과, 동맥경화증 예방 및 완화작용, 혈액내 총- 및 LDL-콜레스테롤 및 TG(중성지방; triglyceride)를 낮춰주고, 당뇨병 치료효과 등의 다양한 생리활성을 나타내는 것으로 알려져 있다 (PARK YK et al., 1997 Lipids 32: 853-858; McCarty MF 2000. Medical hypotheses 55: 187-188). Conjugated Linoleic Acid (CLA) is an isomer of linoleic acid and has a conjugated double bond structure. It has anticancer activity, reduction of body fat, prevention and alleviation of arteriosclerosis, blood total- and LDL-cholesterol and TG (triglyceride; (PARK YK et al., 1997 Lipids 32: 853-858; McCarty MF 2000. Medical hypotheses 55: 187-188), which are known to lower triglyceride levels and to exhibit various physiological activities such as diabetic therapeutic effects.
리놀레산은 9번과 12번 탄소에서 cis 형태의 이중결합을 갖는데 반하여, 공액리놀레산의 이중결합 위치는 9번과 11번, 10번과 12번 및 11번과 13번이고 이중결합 형태도 cis - cis , cis - trans , trans - cis , trans - trans 등이 있어서 총 12개의 공액리놀레산 이성질체의 존재가 알려져 있다.Linoleic acid has cis - type double bonds at 9 and 12 carbons, whereas double bond positions of conjugated linoleic acid are 9 and 11, 10 and 12, 11 and 13, and double bond type cis - cis , cis - trans , trans - cis , trans - trans and so on, the existence of twelve conjugated linoleic acid isomers is known.
반추위 동물에서 유래한 육류에는 공액리놀레산(CLA)이 아주 낮은 농도로 함유되어 있고, 유산균 발효식품, 특히 요구르트에는 탈지유를 사용하기 때문에 공액리놀레산(CLA)은 극미량으로 존재한다. 또한, 두유 등의 콩 관련 식품에는 공액리놀레산(CLA)이 존재하지 않는다. Conjugated linoleic acid (CLA) is present in very low concentrations in meat derived from rumen, and because of the use of skim milk in fermented foods of lactic acid bacteria, especially yogurt. In addition, there is no conjugated linoleic acid (CLA) in soy-related foods such as soy milk.
공액리놀레산(CLA)은 화학적으로 합성하거나 미생물에 의해 생산된다. 화학적으로 합성할 경우에는 고가의 장비를 필요로 하거나, 공정에 너무 많은 시간이 소요되는 등의 문제가 많고, 공액리놀레산(CLA)의 이성질체가 모두 생산될 가능성이 있어서 비효율적이다. 미생물에 의해서는 cis-9, trans-11 공액리놀레산(CLA)가 주로 생산되는데, 생산된 CLA의 분리 공정의 시간 및 비용을 고려하면, CLA를 생성할 수 있는 미생물의 균체 자체를 직접 첨가하여 CLA를 간접적으로 생성하도록 하는 방법 즉 생균제제로서의 사용이 더 추천되어 왔다 (특허 1201184호).The conjugated linoleic acid (CLA) is chemically synthesized or produced by microorganisms. When chemically synthesized, expensive equipments are required, or the process takes too much time, and there is a possibility that all the isomers of conjugated linoleic acid (CLA) are produced, which is inefficient. By micro-organisms is cis -9, trans -11 conjugated linoleic acid (CLA) that is mainly produced, in consideration of the time and cost of the separation process of the produced CLA, it was added to the cells of the microorganism itself capable of producing a directly CLA CLA (I. E., Patent No. 1201184). ≪ / RTI >
생균제제 (프로바이오틱스; probiotics)는 장내 미생물 균형에 도움을 주는 미생물, 항균 활성 또는 효소 활성을 가진 미생물, 및 그들이 생산해 내는 생산물을 말한다(Fuller, R. J Appl Bacteriol. 66(5):365-378, 1989). 아울러 생균제제는 사람이나 동물에 건조된 세포형태나 발효산물 형태로 공급되어 사람이나 동물 숙주의 장내 균총을 개선함으로서 좋은 영향을 주는 단일 또는 복합 균주 형태의 생균으로 정의되고 있다. 생균제제가 갖추어야 할 특성은 인간의 장내를 서식지로 하고, 비병원성, 무독성, 장으로 가는 동안 살아남아야 한다. 더 나아가서 전달 식품 안에서 소비되기 전에 생존율과 활성을 유지 및 감염 예방으로 사용되는 항생제에 대해 민감해야 하며, 항생제 내성을 갖는 플라스미드를 보유하지 않아야 한다. 또한 장내 환경에서 산, 효소, 담즙에 대한 내성을 갖추어야 한다(Mishra, C. et al., Asia Pacific J Clin Nutr. 5:20-24, 1996). Probiotics are microorganisms that help balance intestinal microbes, microorganisms with antimicrobial or enzymatic activity, and products they produce (Fuller, R. J Appl. Bacteriol. 66 (5): 365-378 , 1989). In addition, the probiotic agent is defined as a single or complex strain of live bacteria which is supplied in the form of a dried cell or fermentation product to a human or an animal, and which has a good effect by improving intestinal microflora of a human or animal host. Probiotic agents should survive on the way to non-pathogenic, non-toxic, intestinal, with human intestinal tract as a habitat. Furthermore, it should be susceptible to antibiotics used to maintain viability and activity and to prevent infection prior to consumption in the food product, and should not have plasmids resistant to antibiotics. In addition, resistance to acids, enzymes, and bile in the intestinal environment should be established (Mishra, C. et al., Asia Pacific J Clin Nutr 5: 20-24, 1996).
그러나 현재까지 확인된 CLA 생산 균주들은 CLA 생산성이 낮거나, 섭취 후 위를 통과하는 과정에서 잔존하지 못하며 생균제제로서의 역할이 미약한 것으로 나타났다. 따라서, 우수한 CLA 생산 능력과 함께, 체내에서 높은 생존력과 활성을 나타내서 생균제제로 사용될 수 있는 균주에 대한 발명은 여전히 과제로 남아있다.However, the CLA-producing strains identified so far have not shown a low CLA productivity, remain in the process of passing through the stomach after ingestion, and have little role as probiotics. Therefore, an invention for a strain that can be used as a probiotic agent due to its high survival ability and activity in the body, together with excellent CLA production ability, still remains as a problem.
콩은 우수한 식물성 단백질(35 ~ 45%)과 지방질(10 ~ 15%)의 급원으로 특히 한국 사람에게는 두부, 장류, 두유, 콩기름 등의 식품의 형태로 소비되고 있다. 콩은 영양학적 측면뿐만 아니라 사포닌, 이소플라본, 레시틴와 같은 생리활성 물질에 관한 연구가 활발해지면서 항암, 항동맥경화 및 혈당강화 등의 건강기능성 효과가 주목되어 기능성 식품으로 각광받고 있다. 특히 콩 지방의 50% 이상이 리놀레산인바, 이 리놀레산을 CLA로 효율적으로 전환할 수 있는 생균제제에 관한 개발이 또한 요구되어 왔다.
Soybean is a source of excellent vegetable protein (35 ~ 45%) and fat (10 ~ 15%) and is consumed especially in Korean food such as tofu, soybean paste, soy milk and soybean oil. As a result of research on physiologically active substances such as saponin, isoflavone, and lecithin as well as nutritional aspects of soybeans, attention has been paid to health functional effects such as anticancer, anti-arteriosclerosis, Particularly, since more than 50% of the soybean fat is linoleic acid, there has been a demand for development of a probiotic agent capable of efficiently converting the linoleic acid into CLA.
종래 기술에서의 요구에 부응하기 위해 연구를 지속한 결과, 본 발명자들은 공액리놀레산(CLA) 생산성이 매우 우수하고 생균제제로 사용될 수 있는 특성을 가진 신규한 락토바실러스 플란타륨 (Lactobacillus plantarum) 균주를 분리, 동정함에 따라 본 발명을 완성하게 되었다. As a result of continuing the study to meet the demand in the prior art, the present inventors have found that a novel Lactobacillus plant ( Lactobacillus ( Lactobacillus )) having a very high productivity of conjugated linoleic acid (CLA) plantarum ) was isolated and identified, thereby completing the present invention.
따라서 본 발명의 목적은 CLA 생산성이 우수하면서 내산성 및 내담즙산성을 갖는 신규한 락토바실러스 플란타륨 균주를 제공하는 것이다. Accordingly, an object of the present invention is to provide a novel Lactobacillus plantarum strain having excellent acid-fastness and bile acid resistance with excellent CLA productivity.
본 발명의 또 다른 목적은 본 발명의 균주 또는 이의 배양물을 유효성분으로 하는 생균제제를 제공하는 것이다. It is still another object of the present invention to provide a prophylactic agent comprising the strain of the present invention or a culture thereof as an active ingredient.
또한 본 발명의 목적은 본 발명의 균주 또는 이의 배양물을 이용한 CLA의 함량이 증대된 식품의 제조방법 및 이로부터 제조된 CLA의 함량이 증대된 식품을 제공하는 것이다.
It is also an object of the present invention to provide a method for producing a food having an increased content of CLA using the strain of the present invention or a culture thereof and a food having an increased content of CLA prepared therefrom.
상기 목적을 달성하기 위하여, 본 발명은 내산성, 내담즙산성 및 CLA 생성성이 우수한 신규한 락토바실러스 플란타륨 S48과 P1201 균주를 제공한다. In order to achieve the above object, the present invention provides novel Lactobacillus plantai S48 and P1201 strains excellent in acid resistance, bile acid resistance and CLA production.
본 발명자들은 발효식품 (김치, 젓갈, 막걸리, 간장 및 식물추출발효음료)로부터 다양한 젖산균 종들을 분리하여 리놀레산이 첨가된 MRS 액체배지에서 CLA를 생성하는 균주들이 선발한 후, 내산성, 인공위액 내성 및 담즙산 내성 시험을 통하여 생균제제로 사용될 수 있는 특성과 CLA 생산성이 탁월한 균주를 분리, 동정하여 본 발명에 따른 균주들을 확인하게 되었다. 본 발명에 따른 균주들은 각각 '락토바실러스 플란타륨 S48' 및 '락토바실러스 플란타륨 P1201'로 명명되고 국립농업과학원 농업유전자원센터 (KACC)에 2013년 8월 13일에 기탁되었다 (수탁번호: KACC 91849P 및 KACC 91848P).The present inventors isolated various lactic acid bacterial species from fermented foods (kimchi, salted fish, fermented soy sauce, fermented soy sauce, and fermented soybeans) and selected strains that produce CLA in the MRS liquid medium supplemented with linoleic acid. By isolating and identifying the strains which can be used as probiotic agent and excellent CLA productivity through the bile acid tolerance test, the strains according to the present invention were identified. The strains according to the present invention were named 'Lactobacillus plantai S48' and 'Lactobacillus plantai P1201' respectively and deposited on August 13, 2013 at the National Institute of Agricultural Science and Technology (KACC) : KACC 91849P and KACC 91848P).
락토바실러스 플란타륨 S48 및 P1201 균주의 확인은 형태학적 관찰로 평판배지와 그람염색 관찰을 이용하였고 (도 1의 A ~ F 및 도 2), 생리/생화학적 특성 규명은 당이용성 검정방법인 API CHB50 키트를 이용하였으며, 균주의 세포벽 지방산 분석(MIDI 분석) 및 16S rDNA 염기서열 분석을 통하여 확인하였다. 16S rRNA 염기서열을 바탕으로 한 본 발명의 균주, 락토바실러스 플란타륨 S48 및 P1201이 락토바실러스속 균주들에 속함을 확인하였다 (도 3). Identification of Lactobacillus plantarum S48 and P1201 strains was performed using a plate culture medium and a Gram stain (morphological observation) (FIGS. 1A to F and FIG. 2), and physiological / biochemical characterization was performed using an API CHB50 kit was used, and cell wall fatty acid analysis (MIDI analysis) and 16S rDNA sequencing of the strain were confirmed. It was confirmed that the strains of the present invention based on the 16S rRNA base sequence, Lactobacillus plantai S48 and P1201 belong to Lactobacillus sp. Strains (Fig. 3).
본 발명에 따른 균주, 락토바실러스 플란타륨 S48 및 P1201는 CLA 생성성이 종래 균주들에 비하여 훨씬 우수하다 (표 1). The strains according to the present invention, Lactobacillus plantai S48 and P1201, are more excellent in CLA producibility than the conventional strains (Table 1).
본 발명의 또 다른 목적에 따라서, 본 발명의 균주, 락토바실러스 플란타륨 S48, P1201 또는 이의 배양물을 유효성분으로 하는 생균제제 (probiotics)를 제공한다. According to another object of the present invention, there is provided a probiotics comprising the strain of the present invention, lactobacillus plantai S48, P1201 or a culture thereof as an active ingredient.
생균제제는 건조된 세포 형태나 발효 조성물 등 여러 형태로 공급될 수 있다. 본 발명에 따른 생균제제는 그 균주를 안전한 발효식품에서 선별하였으므로 안전성이 담보되어 독성 없는 생균제제로서 유용하게 이용될 수 있다. 따라서 본 발명에 따른 생균제제는 인간을 포함하는 동물의 식용으로 사용될 수 있으며, 구체적으로는 식품에 사용될 수 있다. The probiotics can be supplied in various forms such as dried cell form or fermented composition. Since the probiotics according to the present invention are selected from safe fermented foods, the strains can be used as a non-toxic probiotics because they are secured. Therefore, the probiotics according to the present invention can be used for the edible use of animals including humans, and specifically for food.
본 발명의 또 다른 목적에 따라서, 본 발명의 균주, 락토바실러스 플란타륨 S48, P1201 또는 이의 배양물을 이용한 CLA의 함량이 증대된 식품의 제조방법을 제공한다. According to another object of the present invention, there is provided a method for producing a food product in which the content of CLA is increased using the strain of the present invention, Lactobacillus plantaitum S48, P1201 or a culture thereof.
본 발명에 따른 CLA의 함량이 증대된 식품의 제조방법은, 본 발명에 따른 균주를 첨가하여 20 ~ 40 ℃에서 12 시간이상 발효시키는 단계를 포함하는 것을 특징으로 한다. The method for producing a food having an increased content of CLA according to the present invention comprises the step of adding a strain according to the present invention and fermenting at 20 to 40 ° C for 12 hours or more.
균주의 첨가량은 1.0%(v/v) ~ 10.0%(v/v) 범위에서 가능하다.The amount of the strain added can be in the range of 1.0% (v / v) to 10.0% (v / v).
본 발명에서 식품은 콩제품 (두유, 두부, 콩고기, 콩스택, 콩과자), 유제품 (우유, 치즈), 발효유 (액상 요구르트, 호상 요구르트), 발효식품 (김치류, 장류, 피클), 발효 음료 등이 될 수 있으나 이에 제한되지는 않는다.In the present invention, the food may be a soybean product (soymilk, tofu, soybean meal, soybean stack, soybean cake), dairy product (milk, cheese), fermented milk (liquid yogurt, yogurt yogurt), fermented food (kimchi, But are not limited thereto.
본 발명의 제조방법에서, 발효 전에, 식품의 재료에 셀룰라제, 프로테아제 및/또는 에스테라제의 효소를 처리하여 자유-리놀레산의 생산을 증진시키는 단계를 포함할 수 있다. 효소 처리량은 식품의 재료에 따라 당업자가 용이하게 정할 수 있다. 바람직하게는 각 효소의 처리량은 1 ~ 10 unit 사이이며, 10 unit 이상에서는 생성량에는 큰 영향을 미치지 않는다. 이와 같은 효소처리에 의해 CLA 생산성을 1.5 ~ 2 배가량 증가시킬 수 있다. In the production process of the present invention, it may include a step of treating the food material with an enzyme of cellulase, protease and / or esterase before fermentation to promote the production of free-linoleic acid. The enzyme throughput can be easily determined by a person skilled in the art depending on the material of the food. Preferably, the throughput of each enzyme is between 1 and 10 units, and the production amount is not significantly affected by more than 10 units. By such an enzyme treatment, CLA productivity can be increased by 1.5 to 2 times.
또한 본 발명의 CLA의 함량이 증대된 식품의 제조방법에서, 발효 전에, 리놀레산 함량이 높은 식물성 유지를 추가할 수 있다. In addition, in the method for producing foods in which the CLA content of the present invention is increased, vegetable oil having a high content of linoleic acid can be added before fermentation.
리놀레산 함량이 높은 식물성 유지로는 홍화씨유 (77.0%), 달맞이꽃씨유 (75.0%) 및 구찌뽕씨유 (68.4%)가 바람직하나 이에 한정되는 것은 아니다. Vegetable oils with high linoleic acid content are preferably safflower seed oil (77.0%), evening primrose oil (75.0%) and gucci mulberry seed oil (68.4%).
본 발명의 제조방법에서 식물성 유지의 첨가량은 0.1 ~ 5.0%(v/v) 이고, 1 ~ 2%(v/v)이 바람직하다.In the production method of the present invention, the addition amount of the vegetable oil is 0.1 to 5.0% (v / v), preferably 1 to 2% (v / v).
본 발명의 제조방법의 일례로서, As an example of the production method of the present invention,
콩을 수침한 후 분쇄하여 콩 분쇄액을 제조하고, The soybean was soaked and pulverized to prepare a bean pulverized liquid,
콩 분쇄액을 증자처리하고, The soybean pulverizing solution was subjected to a thickening treatment,
증자된 콩 분쇄액에 셀룰라제, 프로테아제 및/또는 에스테라제의 효소를 1 ~ 10 unit 처리하여 콩 가수분해물을 제조하고, 1 to 10 units of an enzyme of a cellulase, a protease and / or an esterase is added to the soybean pulverized solution to prepare a soybean hydrolyzate,
콩 가수분해물에 본 발명의 균주를 접종하여 20 ~ 40 ℃에서 12 시간이상 발효시키는 것으로 이루어지는 CLA 함량이 증대된 콩제품의 제조방법을 제공한다. The present invention provides a method for producing a soybean product in which the strain of the present invention is inoculated to a soybean hydrolyzate and fermented at 20 to 40 캜 for 12 hours or more to thereby increase the content of CLA.
증자처리는 100 ~ 120 ℃에서 30 ~ 60분간 행하는 것이 바람직하다. It is preferable to perform the thickening treatment at 100 to 120 DEG C for 30 to 60 minutes.
효소 처리는 1 ~ 10 unit 첨가하여 30 ~ 40 ℃에서 12 시간이상 처리하여 이루어진다. Enzyme treatment is performed by adding 1 ~ 10 units and treating at 30 ~ 40 ℃ for more than 12 hours.
또한 본 발명의 CLA의 함량이 증대된 콩제품의 제조방법에서, 증자 후에, 리놀레산 함량이 높은 식물성 유지를 추가할 수 있다. Further, in the method for producing a soybean product in which the content of CLA of the present invention is increased, vegetable oil having a high content of linoleic acid can be added after the planting.
본 발명의 또 다른 목적에 따라서, 본 발명의 균주, 락토바실러스 플란타륨 S48, P1201 또는 이의 배양물을 이용하여 제조된 CLA의 함량이 증대된 식품을 제공한다. 본 발명에서 CLA 함량이 증대된 식품의 종류에는 콩제품 (두유, 두부, 콩고기, 콩스낵, 콩과자), 유제품 (우유, 치즈), 발효유 (액상 요구르트, 호상 요구르트), 발효식품 (김치류, 장류, 피클), 발효 음료 등이 있으나 이에 제한되지는 않는다.
According to still another object of the present invention, there is provided a food having an increased content of CLA prepared using the strain of the present invention, Lactobacillus plantai S48, P1201 or a culture thereof. In the present invention, the types of foods having increased CLA content include soybean products (soybean milk, tofu, soybean meal, soybean snack, soybean cake), dairy products (milk and cheese), fermented milk (liquid yogurt, yogurt yogurt), fermented foods Pastries, pickles), fermented beverages, and the like.
본 발명의 신규한 락토바실러스 플란타륨 S48 균주 및 P1201 균주는 CLA 생산성이 우수하여 CLA이 증대된 식품이 제조에 사용될 수 있다. 또한 본 발명의 균주들은 내산성 및 내담즙산성을 가져서 생균제제로 활용성이 크다. The novel Lactobacillus plantarum S48 strain and P1201 strain of the present invention are excellent in CLA productivity and can be used for production of CLA-enhanced foods. In addition, the strains of the present invention have acid resistance and bile acid resistance, and thus are highly utilizable as probiotics.
본 발명에 따른 균주 및 이의 배양물로 제조된 식품은 CLA의 함유량이 증대되어서, 체중감량, 콜레스테롤 저하, 고지혈증 개선 및 동맥경화 완화 등에 상승적인 효과를 발휘하는 기능성 식품으로 사용될 수 있다. The strains according to the present invention and foods made from the cultures of the present invention can be used as functional foods that exhibit a synergistic effect on weight loss, cholesterol lowering, hyperlipidemia improvement, and atherosclerosis relief by increasing the content of CLA.
본 발명의 CLA 함유 식품의 제조방법은 CLA 생산성이 높은 본 발명의 균주를 이용함과 더불어, 효소처리를 추가하여 통상의 방법에 비하여 CLA의 생산성을 훨씬 증대시킬 수 있다.
The method of producing a CLA-containing food of the present invention can further increase the productivity of CLA compared to the conventional method by using the strain of the present invention having high CLA productivity and adding an enzyme treatment.
도 1은 본 발명에서 선발된 16 균주의 MRS 평판배지에서의 클론 형태를 보여주는 사진이다 (A: S48, B: S52, C: S56, D: S64, E: S65, F: P1201, G: K23, H: K24, I: D56, J: D58, K: 13; L: 14, M: 15, N: 29, O: 41, P: 104).
도 2은 본 발명에서 선발된 16 균주의 그람염색 사진이다 (A: S48, B: S52, C: S56, D: S64, E: S65, F: P1201, G: K23, H: K24, I: D56, J: D58, K: 13; L: 14, M: 15, N: 29, O: 41, P: 104).
도 3은 본 발명에 따른 락토바실러스 플란타륨 S48 및 P1201 균주의 락토바실러스 속에서의 상동성 관계를 보여주는 계통도이다.
도 4은 리놀레산 농도에 따른 락토바실러스 플란타륨 S48 및 P1201 균주의 균 생육 정도 및 CLA 생산성을 나타내는 그래프이다 (4a: 락토바실러스 플란타륨 S48의 균 생육 정도, 4b: 락토바실러스 플란타륨 S48의 CLA 생산성, 4c: 락토바실러스 플란타륨 P1201의 균 생육 정도, 4d: 락토바실러스 플란타륨 P1201의 CLA 생산성).
도 5은 추가된 홍화씨유의 농도에 따른 락토바실러스 플란타륨 S48 및 P1201 균주의 균 생육 정도 및 CLA 생산성을 나타내는 그래프이다 (5a: 락토바실러스 플란타륨 S48의 균 생육 정도, 5b: 락토바실러스 플란타륨 P1201의 균 생육 정도, 5c: 락토바실러스 플란타륨 S48의 CLA 생산성, 5d: 락토바실러스 플란타륨 P1201의 CLA 생산성).
도 6는 홍화씨유를 첨가하고 본 발명에 따른 균주를 이용하여 콩제품의 제조 시에 CLA 생산성이 증대함을 보여주는 그래프이다 (6a: 락토바실러스 플란타륨 S48의 대원콩 가수분해물에서 CLA 생산성, 6b: 락토바실러스 플란타륨 S48의 대풍콩 가수분해물에서 CLA 생산성, 6c: 락토바실러스 플란타륨 S48의 늘찬콩 가수분해물에서 CLA 생산성, 6d: 락토바실러스 플란타륨 S48의 대풍콩 가수분해물 48시간째의 GC-크로마토그램, 6e: 락토바실러스 플란타륨 P1201의 대원콩 가수분해물에서 CLA 생산성, 6f: 락토바실러스 플란타륨 P1201의 대풍콩 가수분해물에서 CLA 생산성, 6g: 락토바실러스 플란타륨 P1201의 늘찬콩 가수분해물에서 CLA 생산성, 6h: 락토바실러스 플란타륨 P1201의 대풍콩 가수분해물 48시간째의 GC-크로마토그램).FIG. 1 is a photograph showing clone morphology in 16 strains of MRS flat plate culture selected in the present invention (A: S48, B: S52, C: S56, D: S64, E: S65, F: P1201, , H: K24, I: D56, J: D58, K: 13, L: 14, M: 15, N: 29, O: 41, P: 104).
2 is a Gram stain image of 16 strains selected in the present invention (A: S48, B: S52, C: S56, D: S64, E: S65, F: P1201, G: K23, H: D56, J: D58, K13, L14, M15, N19, O41, P104).
FIG. 3 is a flow diagram showing the homology relationship between Lactobacillus plantai S48 and P1201 strains in the genus Lactobacillus according to the present invention.
4 is a graph showing the degree of bacterial growth and CLA productivity of Lactobacillus platelets S48 and P1201 according to the concentration of linoleic acid (4a: degree of bacterial growth of Lactobacillus plantai S48, 4b: degree of bacterial growth of Lactobacillus plantarium S48 CLA productivity, 4c: degree of bacterial growth of Lactobacillus plantai P1201, and 4d: CLA productivity of Lactobacillus plantai P1201).
FIG. 5 is a graph showing the degree of bacterial growth and CLA productivity of Lactobacillus platelets S48 and P1201 according to the concentration of added safflower seed oil (5a: degree of bacterial growth of Lactobacillus plantai S48, 5b: 5c: CLA productivity of Lactobacillus plantarium S48, and 5d: CLA productivity of Lactobacillus plantai P1201).
FIG. 6 is a graph showing that the productivity of CLA is increased during the production of soybean products by adding the safflower seed oil according to the present invention (6a: CLA productivity in the soybean hydrolyzate of Lactobacillus plantai S48, 6b : CLA Productivity in Daphne Soybean Hydrolyzate of Lactobacillus plantai S48, 6c: CLA Productivity in Always Chan Hydrolyzate of Lactobacillus Plantai S48, 6d: Daphne Soybean Hydrolyzate of Lactobacillus Plantai S48 at 48 hours 6e: CLA productivity in the soybean hydrolyzate of Lactobacillus plantai P1201, 6f: CLA productivity in the soybean hydrolyzate of Lactobacillus plantai P1201, 6g: Lactobacillus plantai P1201, CLA productivity in hydrolyzate, 6h: GC-chromatogram at 48 hrs. Of Lactobacillus plantai P1201).
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안 된다.
The present invention will be described in more detail by the following examples. These examples are provided for illustrating the present invention, and the scope of the present invention should not be limited thereby.
실 시 예Example
실시예 1. 균주 분리Example 1 Isolation of Strain
김치, 막걸리, 간장, 젖갈 및 산야초효소(설탕추출) 발효음료로부터 각각 10 m1 시료를 채취하여 90 ml 생리식염수에 넣은 후 10단 희석법으로 104 ~ 108까지 희석한 후 희석액 0.1 ml을 취하여 Lactobacilli MRS 배지(DIFICO 사)에 접종하였다. 멸균 생리식염수(0.5% w/v)로 30~150개 정도의 균락(colony)이 생기도록 희석하여 Lactobacilli MRS 배지에 도말한 후, 30 ~ 35 ℃로 유지시킨 항온 배양기에서 72시간 배양하고, 배양된 배지에서 300개 정도의 균락을 임의 선택하여 각 균주를 MRS 배지에 2회 계대배양한 후, 20 ml 시험관에 1% 접종한 후, MRS 액체배지 5 ml에 소 혈청 알부민(bovine serum albumin)이 혼합된 리놀레산 유화액(Sigma-Arich Co.)을 0.02% (100 μg/ml) 첨가하여 48 시간 배양하였다. 10 m1 samples were taken from fermented beverages of Kimchi, Makgeolli, Soybean, Pancreas and Sanayasia (sugar extracted) and put into 90 ml of physiological saline, diluted to 10 4 to 10 8 by 10-step dilution, and then 0.1 ml of diluted solution was added to Lactobacilli MRS medium (DIFICO). The cells were plated on Lactobacilli MRS medium with sterilized physiological saline (0.5% w / v) to give 30 ~ 150 colony, and then cultured for 72 hours in a constant temperature incubator maintained at 30 ~ 35 ° C. Each strain was subcultured twice in MRS medium and then inoculated 1% in 20 ml test tube. Bovine serum albumin was added to 5 ml of MRS liquid medium. 0.02% (100 μg / ml) of mixed linoleic acid emulsion (Sigma-Arich Co.) was added and cultured for 48 hours.
배양액 2 ml에 클로로포름 : 메탄올 (1 : 1) 혼합용액을 가하여 추출하고 통상적인 지방산 전처리 방법으로 지방산을 추출하여 가스크로마토그래피(gas chromatograph, GC)를 이용하여 측정하였고 리놀레산(LA) 및 공액리놀레산(CLA) 표준곡선을 잡아서 CLA 생성량을 비교하여, CLA를 생성하는 16 균주를 선발하였다. The fatty acid was extracted by the usual fatty acid pretreatment method and analyzed by gas chromatograph (GC), and the concentrations of linoleic acid (LA) and conjugated linoleic acid (1: 1) CLA) standard curve to compare the amount of CLA produced, and 16 strains producing CLA were selected.
선발된 16 균주들의 MRS 평판배지에서의 클론 형태를 도 1에 나타내고, 그람 염색 사진을 도 2에 나타냈다.
Clonal morphology of 16 selected strains on MRS plate culture medium is shown in Fig. 1, and Gram staining photograph is shown in Fig.
실시예 2. 균주의 CLA 생산성 측정Example 2. Measurement of CLA Productivity of a Strain
실시예 1에서 선발된 최종 16종 균주들의 CLA 생산성을 측정하였다. The CLA productivity of the final 16 strains selected in Example 1 was measured.
구체적으로는 리놀레산 유화액 0.02% (100 μg/ml)을 MRS 액체배지 및 8% 탈지유 배지에 각각 첨가한 후, 실시예 1의 각각의 균주를 2.5% 접종하고 37 ℃에서 48 시간 배양한 후 CLA 생산량을 측정하였다. Specifically, 0.02% (100 μg / ml) of linoleic acid emulsion was added to each of the MRS liquid medium and the 8% skim milk medium, and each strain of Example 1 was inoculated at 2.5% and cultured at 37 ° C. for 48 hours. Were measured.
CLA 생산량 측정은 각각의 배양액 2 ml을 취하여 클로로포름 : 메탄올 (1 : 1) 2 ml을 가하여 지방산을 추출하고 추출된 지방에 검화 및 메칠화 과정 후 여과하여 식품공전의 일반성분분석법 중 지방산 분석 방법에 준하여 GC 크로마토그램을 이용하여 분석하였고, 그 결과를 표 1에 나타냈다. For CLA production, 2 ml of each culture was taken, and 2 ml of chloroform: methanol (1: 1) was added to extract the fatty acid. The extracted fat was filtered through the saponification and methylation process and analyzed by fatty acid analysis The results are shown in Table 1. The results are shown in Table 1. < tb > < TABLE >
균주
Strain
MRS
MRS
탈지유
Skim milk
상기 표에서 확인되는 바와 같이, S48과 P1201 균주는 cis-9,trans-11과 trans-10,cis-12를 동시에 생성하면서 각각 38.59 μg/ml 및 40.21 μg/ml의 CLA를 생성했던바, CLA의 생성량이 다른 균주들에 비하여 현저히 많았다.
As shown in the above table, strains S48 and P1201 produced 38.59 μg / ml and 40.21 μg / ml CLA, respectively, while simultaneously producing cis- 9, trans- 11 and trans- 10 and cis- Was significantly higher than that of other strains.
실시예 3. 균주의 생균제제능 검사Example 3. Probiotic insecticidal test of strain
실시예 1에서 선발된 16종의 균주의 생균제제로서 사용 가능 여부를 판단하기 위해 산, 인공위액산 및 담즙산에 대한 내성을 확인하였다. Resistance to acid, artificial stomach acid and bile acid was determined in order to determine whether the 16 strains selected in Example 1 could be used as a probiotic agent.
내산성 측정은, 균주들을 MRS 액체배지 (Lactobacilli MRS Broth; DIFCO 사) 에 접종하여 37 ℃에서 48시간 배양한 후, 3M 염산으로 각각 pH 2.0, 2.5 및 3.0으로 조정된 새로운 MRS 액체배지로 106 CFU/ml가 되도록 희석하였다. 희석된 균체들을 37 ℃에서 4시간 동안 배양하였다. 배양 후, 배지 산성도를 중화시키기 위해서 포스페이트 버퍼(0.1 M, pH 6.2)로 균체를 연속적으로 희석시키고 MRS 평판배지 (Lactobacilli MRS Agar; DIFCO 사) 상에 도말하여 30 ℃에서 48시간 배양한 후에 생균수를 측정하였다. 생존율은 초기 균의 농도와 MRSA 평판배지 상에 형성된 Lactobacillus sp . 균의 콜로니의 비율을 비교하여 계산하였고, 그 결과를 표 2에 나타내었다. The acid resistance was measured by incubating the strains at 37 ° C for 48 hours in a MRS liquid medium (Lactobacilli MRS Broth; DIFCO), adding 10 6 CFU to the new MRS liquid medium adjusted to pH 2.0, 2.5 and 3.0 respectively with 3M hydrochloric acid / ml. The diluted cells were incubated at 37 DEG C for 4 hours. After incubation, the cells were continuously diluted with phosphate buffer (0.1 M, pH 6.2) to neutralize the acidity of the culture medium, plated on MRS plate medium (Lactobacilli MRS Agar; DIFCO), and cultured at 30 ° C for 48 hours. Were measured. Survival rates were determined from the initial bacterial concentration and Lactobacillus sp . And the ratio of colonies of bacteria was calculated. The results are shown in Table 2.
균주
Strain
인공위액 내성을 측정은, MRSB 액체배지에 1% 펩신을 첨가하여 각각 pH 2.0, 2.5 및 3.0으로 맞춰 인공위액을 만들었다. 이 후 실험은 상기에서 설명된 내산성 측정과 동일하게 실시하였고 그 결과를 표 3에 나타내었다.The artificial gastric juice resistance was measured by adding 1% pepsin to the MRSB liquid medium and adjusting the pH to 2.0, 2.5 and 3.0 respectively. The test was carried out in the same manner as the acid resistance measurement described above, and the results are shown in Table 3.
균주
Strain
내담즙성 측정은 다음과 같이 실시하였다. 30 ℃에서 48시간 동안 MRS 액체배지에서 배양한 균체 15㎖ (106 CFU/ml과 동일한)를 다른 농도(1, 2, 3, 4% w/v)의 우담(oxgall bile)을 함유한 MRS 평판배지 상에 스팟(spotting)한 후, 30 ℃에서 5일 동안 배양하였다. 균주들에 대한 담즙산 최소억제농도(MIC)는 스팟을 육안검사로 판정함으로써 스팟에서 균 생장을 저해시키는 최소농도로서 결정하였다. 육안검사 판정 기준은 직영 15 mm인 경우 +++, 10mm인 경우 ++, 8 mm인 경우 +, 0 mm인 경우 - 로 하였다. 육안 검사 결과는 표 4에 나타내었다.The measurement of the biliary properties was carried out as follows. 15 ml (same as 10 6 CFU / ml) of the cells cultured in the MRS liquid medium for 48 hours at 30 ° C were treated with MRS containing oxgall bile at different concentrations (1, 2, 3, 4% w / v) Spotted on a plate culture medium, and then cultured at 30 DEG C for 5 days. The minimum inhibitory concentration (MIC) of bile acid for the strains was determined as the minimum concentration that inhibited bacterial growth in the spot by spotting by visual inspection. The criteria for visual examination were +++ for 15 mm directly, ++ for 10 mm, + for 8 mm, and - for 0 mm. The visual inspection results are shown in Table 4.
Strain
상기 표들에서 확인할 수 있듯이, 본 발명에 따른 균주, 락토바실러스 플란타륨 S48 및 P1201가 선발된 균주들 중에서 산 및 인공위액산에 내성이 가장 뛰어났으며, pH 2.0에서도 2시간째 약 50% 정도의 생존률이 나타냈고, 담즙산의 경우는 은 4%에서도 생육이 가능하였다. 따라서 본 발명에 따른 균주, 락토바실러스 플란타륨 S48 및 P1201가 균주는 생균제제로 충분히 사용될 수 있음을 알 수 있다.
As can be seen from the above tables, the strains according to the present invention were most resistant to acid and artificial gastric acid among the strains selected for Lactobacillus platelets S48 and P1201, and about 50% at 2 hours even at pH 2.0 , And the survival rate of bile acid was 4%. Therefore, it can be seen that the strains according to the present invention, Lactobacillus plantai S48 and P1201 strains can be sufficiently used as a probiotic agent.
실시예 4. 락토바실러스 플란타륨 S48 및 P1201 균주의 동정Example 4. Identification of Lactobacillus plantai S48 and P1201 strains
상기 실시예들에서 CLA 생산성이 우수하면서도 내산성, 인공위액 내성 및 담즙산 내성이 우수하였던 락토바실러스 플란타륨 S48 및 P1201 균주를 선발하고, 이 균주들의 형태학적, 생리학적, 생화학적, 분자유전학적 특성을 조사하였다.Lactobacillus platelets S48 and P1201, which had excellent CLA productivity and excellent acid resistance, artificial gastric juice resistance and bile acid tolerance, were selected and the morphological, physiological, biochemical and molecular genetic characteristics Respectively.
락토바실러스 플란타륨 S48 균주는 그람양성균이었고, 간균으로 세포벽 지방산 분석 결과, 주된 지방산인 C16:0와 C18:1 w9c의 형태가 각각 31.52%와 23.86%를 차지하였다. 락토바실러스 플란타륨 P1201 균주는 그람양성균이었고, 간균으로 세포벽 지방산 분석(MIDI) 결과, 주된 지방산인 C16:0와 C18:1 w9c의 형태가 약 55.31%을 차지하였다 (표 5).The Lactobacillus plantarum S48 strain was Gram positive bacteria. As a result of analysis of cell wall fatty acid as a bacterium, the major fatty acids C16: 0 and C18: 1 w9c were 31.52% and 23.86%, respectively. Lactobacillus plantai P1201 was a Gram-positive bacterium. As a result of amino acid analysis of the cell wall fatty acids (bacterium), the major fatty acids, C16: 0 and C18: 1 w9c, accounted for about 55.31% (Table 5).
지방산 종류
Types of fatty acids
Summed feature 7 - C19:0 CYCLO w10c/C19w6Summed feature 3 - C15: 0 ISO 20H / C16: 1w7c
Summed feature 7 - C19: 0 CYCLO w10c / C19w6
세균의 당이용성 테스트 방법인 API CHB50 키트 (BioMerieux, France)를 사용하여 균주의 생화학적 특성을 살펴본 결과, 락토바실러스 플란타륨 S48 균주는 라이보스(Ribose)을 포함하는 24 종의 탄소원을 자화할 수 있고 통성혐기성의 락토바실러스 속 균주로 추정되었고, 생육가능 온도는 10~40 ℃이었고, 생육 pH는 4.5~11.0임을 확인할 수 있었다. The API CHB50 kit, a method for testing the glycosyltransferase (BioMerieux, France), the Lactobacillus plantarum S48 strain was found to be able to magnetize 24 carbon sources including Ribose and to produce lactic acid bacteria of the lactobacillus genus The growth temperature was 10 ~ 40 ℃ and the growth pH was 4.5 ~ 11.0.
락토바실러스 플란타륨 P1201 균주는 엘-아라비노스(L-Arabinose)을 포함하는 25 종의 탄소원을 자화할 수 있고 통성혐기성의 락토바실러스 속 균주로 추정되었고, 생육가능 온도는 10~40 ℃이었고, 생육 pH는 4.5~10.0임을 확인할 수 있었다(표 6).The Lactobacillus plantai P1201 strain was able to magnetize 25 carbon sources including L-Arabinose and was assumed to be a lactic acid-anaerobic Lactobacillus sp. Strain. The growth temperature was 10 to 40 占 폚, The growth pH was 4.5 ~ 10.0 (Table 6).
No
No
No
분자유전학적 방법으로서 16S rRNA의 염기서열 분석을 수행한 결과, 두 균주는 모두 BLASTN (nucleotidenucleotide BLAST) 데이터베이스를 통해 락토바실러스 플란타륨 균주와 99%의 높은 상동성을 나타낸다는 것을 확인하였다 (도 3).Sequence analysis of 16S rRNA as a molecular genetic method revealed that both strains showed 99% high homology with Lactobacillus plantarum strain through BLASTN (nucleotidenucleotide BLAST) database (Fig. 3 ).
위 형태학적, 생리학적, 분자유전학적 특성 등을 종합하여 상기 동정된 균주를 각각 락토바실러스 플란타륨 S48 및 P1201이라 명명하였다.
The identified strains were named Lactobacillus plantai S48 and P1201, respectively, based on morphological, physiological and molecular genetic characteristics.
실시예 5. 리놀레산 농도에 따른 락토바실러스 플란타륨 S48 및 P1201의 CLA 생산성Example 5 CLA Productivity of Lactobacillus plantarium S48 and P1201 according to Linoleic Acid Concentration
8% 탈지유 액체배지에 리놀레산 유화액을 각각 250, 500 및 1000 μg/ml 첨가하여 락토바실러스 플란타륨 S48과 P1201을 각각 접종한 후 배양시간 0 hr, 12 hr, 24 hr 및 48 hr에 시료를 채취하여 균 생육 정도와 CLA 생성 정도를 측정하였고, 그 결과를 도 4a ~ 도 4d에 나타냈다. After addition of 250, 500 and 1000 μg / ml of linoleic acid emulsion to 8% skim milk liquid medium, Lactobacillus platelets S48 and P1201 were inoculated respectively and samples were collected at
락토바실러스 플란타륨 S48의 생육은 초기 6.0 log cfu/ml 수준에서 24시간째 9.35 ~ 9.64 log cfu/ml로 최대치로 나타낸 후 48시간째 약간 감소하였다 (도 4a). 균주의 생육 정도는 리놀레산의 농도와는 관계없이 비슷한 정도를 나타냈다. Growth of Lactobacillus plattarium S48 was maximal at 9.35 to 9.64 log cfu / ml at 24 hours at the initial 6.0 log cfu / ml level, and slightly decreased after 48 hours (Fig. 4a). The degree of growth of the strain was similar regardless of the concentration of linoleic acid.
CLA 생성량은 배양 48시간째 리놀레산 250 μg/ml 첨가의 경우 cis-9, trans-11는 25.89 μg/ml과 trans-10, cis-12는 19.08 μg/ml 생성되었고, 리놀레산 500 μg/ml 첨가의 경우 cis-9, trans-11는 48.22 μg/ml과 trans-10, cis-12는 41.67 μg/ml 생성되었고, 리놀레산 1000 μg/ml 첨가의 경우 cis-9, trans-11는 51.02 μg/ml과 trans-10, cis-12는 42.64 μg/ml 생성되어 (도 4b), CLA의 생산성은 리놀레산의 농도에 의존적으로 증가함을 확인할 수 있다. CLA production in the case of culture at 48 hours
락토바실러스 플란타륨 P1201의 생육은 초기 6.0 log cfu/ml 수준에서 24시간째 9.41 ~ 9.56 log cfu/ml로 최대치로 나타낸 후 48시간째 약간 감소하였다 (도 4c). 균주의 생육 정도는 리놀레산의 농도와는 관계없이 비슷한 정도를 나타냈다. The growth of Lactobacillus plantai P1201 was maximal at 9.41 to 9.56 log cfu / ml at 24 hours at the initial 6.0 log cfu / ml level and slightly decreased after 48 hours (Fig. 4c). The degree of growth of the strain was similar regardless of the concentration of linoleic acid.
CLA 생성량은 배양 48시간째 리놀레산 250 μg/ml 첨가의 경우 cis-9, trans-11는 27.89 μg/ml과 trans-10, cis-12는 20.47 μg/ml 생성되었고, 리놀레산 500 μg/ml 첨가의 경우 cis-9, trans-11는 48.54 g/ml과 trans-10, cis-12는 41.97 μg/ml 생성되었고, 리놀레산 1000 μg/ml 첨가의 경우 cis-9, trans-11는 50.99 μg/ml과 trans-10, cis-12는 41.03 μg/ml 생성되어 (도 4d), CLA의 생산성은 리놀레산의 농도에 의존적으로 증가함을 확인할 수 있다.
The amount of CLA produced by cis-9, trans-11, and cis- 12 was 250 μg / ml, 27.89 μg / ml and trans- 10 and 20.47 μg / If cis -9, trans -11 was 48.54 g / ml and trans -10, cis -12 in the case of, it was produced 41.97 μg / ml linoleic acid, 1000 μg / ml was added cis -9, trans -11 and is 50.99 μg / ml trans- 10 and cis- 12 were produced at 41.03 μg / ml (FIG. 4d), indicating that the productivity of CLA was increased depending on the concentration of linoleic acid.
실시예Example 6. 6. 홍화씨유Safflower oil 농도에 따른 Depending on concentration 락토바실러스Lactobacillus 플란타륨Pantalum S48S48 및 And P1201P1201 의 of CLACLA 생산성 productivity
8% 탈지분유 액체배지에 홍화씨 기름 유화액을 각각 0.5%, 1.0% 및 2.0%를 첨가하여 락토바실러스 플란타륨 S48과 P1201을 각각 접종한 후 배양시간 0 hr, 12 hr, 24 hr 및 48 hr에 시료를 채취하여 균 생육 정도와 CLA 생성 정도를 측정하였고, 그 결과를 도 5a ~ 도 5d에 나타냈다. Lactobacillus platelets S48 and P1201 were inoculated by adding 0.5%, 1.0% and 2.0% of Safflower oil emulsion to 8% skim milk powder liquid medium, respectively, and incubated at 0 hr, 12 hr, 24 hr and 48 hr Samples were collected and the degree of bacterial growth and the degree of CLA production were measured. The results are shown in Figs. 5A to 5D.
균주의 생육 정도를 살펴본 결과, 초기 약 6.0 log cfu/mL에서 종기 약 10.0 log cfu/mL으로 증가하였다 (도 5a 및 도 5b). 균주의 생육 정도는 홍화씨유 농도와는 관계없이 비슷한 정도를 나타냈다.The degree of growth of the strain was increased from about 6.0 log cfu / mL at the initial stage to about 10.0 log cfu / mL at the stage (Figs. 5A and 5B). The degree of growth of the strain was similar regardless of the concentration of safflower oil.
CLA 생산성을 살펴본 결과, 홍화씨 기름 첨가량이 증가할수록 (농도 의존적으로) CLA 생성은 증가하였으며, 락토바실러스 플란타륨 S48 (cis-9, trans-11는 57.03 μg/ml 및 trans-10, cis-12는 45.02 μg/ml) 보다 락토바실러스 플란타륨 P1201 (cis-9, trans-11는 62.39 μg/ml 및 trans-10, cis-12는 50.22 μg/ml)이 약간 높은 CLA를 생산성을 나타냈다 (도 5c 및 도 5d).
As a result of CLA productivity, the CLA production increased with increasing the amount of oil added to sour milk, and Lactobacillus plantai S48 ( cis- 9, trans- 11, 57.03 μg / ml and trans- 10, cis- 12 It is Lactobacillus Planta volume P1201 (cis -9, trans -11 is 62.39 μg / ml, and trans -10, cis -12 exhibited a slightly higher CLA productivity is 50.22 μg / ml) (Fig than 45.02 μg / ml) 5c and 5d).
실시예Example 7. 7. 락토바실러스Lactobacillus 플란타륨Pantalum S48S48 및 And P1201P1201 을 이용한 Using CLACLA 가 증대된 콩 제품 제조Bean product manufacturing
대원콩, 대풍콩, 늘찬콩의 생콩 분말 및 증자 콩 분말 (6시간 수침한 후 100 ℃에서 30분간 증자하여 50 ~ 55 ℃에서 2 ~ 3일간 건조한 것) 각각 10 g에 정제수 100 ml을 첨가한 후 120 ℃에서 15분간 살균처리하였다. 100 g of purified water was added to 10 g of each of Daewon bean, Daeungbong bean, Soybean bean, Soybean bean powder, Soybean bean powder, and soybean powder (after soaking for 6 hours and drying at 50 to 55 ° C for 30 minutes at 100 ° C for 2 to 3 days) And sterilized at 120 DEG C for 15 minutes.
살균처리된 생콩 및 증자 콩 조성물을 각각 2 그룹으로 나눠서, 하나의 그룹은 그대로 사용하였고, 나머지 하나의 그룹은 셀루라제, 프로테아제 및 에스테라제 (Sigma-Aldrich 사)를 각각 최종 10 unit 되게 첨가하여 37 ℃에서 24시간 동안 처리하여 콩 가수분해물로 제조하여 사용하였다. Sterilized soybean and soy sauce soybean compositions were divided into two groups, one group was used as it is, and the other group was added with cellulase, protease and esterase (Sigma-Aldrich) And treated at 37 ° C for 24 hours to prepare soybean hydrolyzate.
제조된 콩 조성물 및 콩 가수분해물의 각각에 락토바실러스 플란타륨 S48 및 락토바실러스 플란타륨 P1201을 각각 2.5%(2.5 ml) 접종하여 37 ℃에서 48시간 동안 배양한 후, CLA 생성량을 측정하였고, 그 결과를 표 7에 나타냈다. The resulting soybean composition and soybean hydrolyzate were inoculated with 2.5% (2.5 ml) of Lactobacillus plantai S48 and Lactobacillus plantai P1201, respectively, and cultured at 37 ° C for 48 hours. The amount of CLA produced was measured, The results are shown in Table 7.
콩 품종
Soybean variety
조성물Daewon bean
Composition
조성물Daesung bean
Composition
조성물Always a cold
Composition
가수분해물Daewon bean
Hydrolyzate
가수분해물Daesung bean
Hydrolyzate
가수분해물Always a cold
Hydrolyzate
조성물Daewon bean
Composition
조성물Daesung bean
Composition
조성물Always a cold
Composition
가수분해물Daewon bean
Hydrolyzate
가수분해물Daesung bean
Hydrolyzate
가수분해물Always a cold
Hydrolyzate
전체적으로 증자 및 효소처리가 없는 콩 조성물에 비하여, 증자 및 효소처리된 콩 가수분해물을 사용한 경우 높은 CLA를 생산성을 나타냈다. 생콩 분말을 사용한 경우는 배양 24시간부터 겔이 형성되어 세포의 원활한 접촉이 일어나지 않아 CLA 생성량이 적은 것으로 판단되었다.
Compared with the soybean composition, which had no increase or enzyme treatment as a whole, the soybean hydrolyzate treated with increased and enzyme-treated soybean showed high CLA productivity. When the soybean powder was used, it was judged that the gel was formed from the culture for 24 hours, and the smooth contact of the cells did not occur and the CLA production was small.
실시예Example 8. 8. 홍화씨유Safflower oil 첨가에 따른 By addition CLACLA 함유량이 추가 증대된 콩 식품의 제조 Manufacture of soybean food with further increased content
실시예 7에서와 같은 증자 콩 분말 10 g에 정제수 100 ml을 첨가한 후 120 ℃에서 15분간 살균처리하고 홍화씨 기름을 각각 0%, 0.5% 및 1.0% 첨가한 후, 셀룰라제, 프로타아제 및 에스테라제를 각각 최종 10 unit 되게 첨가하여 37 ℃에서 24시간 동안 처리하여 홍화씨 기름 첨가 콩 가수분해물을 제조하였다. 제조된 콩 가수분해물에 락토바실러스 플란타륨 S48 및 락토바실러스 플란타륨 P1201을 각각 2.5%(2.5 ml) 접종하여 37 ℃에서 48 시간 동안 배양한 후, 균 생육 정도를 측정하여 표 8 (락토바실러스 플란타륨 S48) 및 표 9 (락토바실러스 플란타륨 P1201)에 나타냈고, CLA 생성 정도를 측정하여 도 6a ~ 6h에 나타냈다.100 ml of purified water was added to 10 g of the soybean powder as in Example 7, sterilized at 120 ° C for 15 minutes, added with 0%, 0.5% and 1.0% of safflower seed oil, and then the cellulase, protease and Esterase was added to the final 10 units, respectively, and the mixture was treated at 37 ° C for 24 hours to prepare soybean hydrolyzate of oil added with safflower seed oil. The resulting soybean hydrolyzate was inoculated with 2.5% (2.5 ml) of Lactobacillus plantai S48 and Lactobacillus plantai P1201, respectively, and cultured at 37 ° C for 48 hours. The degree of bacterial growth was measured and shown in Table 8 (Lactobacillus Pantotarium S48) and Table 9 (Lactobacillus plantai P1201), and the degree of CLA production was measured and shown in Figs. 6a to 6h.
콩 품종
Soybean variety
시료
sample
대원콩
Daewon bean
대풍콩
Daesung bean
늘찬콩
Always a cold
균주 : 락토바실러스 플란타륨 S48SSPHB: 10% Increase soybean powder hydrolyzate, SF: safflower seed oil
Strain: Lactobacillus plantarium S48
콩 품종
Soybean variety
시료
sample
대원콩
Daewon bean
대풍콩
Daesung bean
늘찬콩
Always a cold
균주 : 락토바실러스 플란타륨 P1201SSPHB: 10% Increase soybean powder hydrolyzate, SF: safflower seed oil
Strain: Lactobacillus plantai P1201
락토바실러스 플란타륨 S48을 사용하여 제조된 콩 제품에서 균주 생육 살펴본 결과, 초기 약 5.4 log cfu/mL 수준에서 48시간 후 9.5 log cfu/mL로 증가하였으며, 균주의 생육 정도는 홍화씨유 농도와는 관계없이 비슷한 정도를 나타냈다 (표 8). 락토바실러스 플란타륨 P1201을 사용하여 제조된 콩 제품에서 균주 생육 살펴본 결과, 초기 약 5.6 log cfu/mL 수준에서 48시간 후 9.5 log cfu/mL로 증가하였으며, 균주의 생육 정도는 홍화씨유 농도와는 관계없이 비슷한 정도를 나타냈다 (표 9). In the soybean cultured with Lactobacillus plantarum S48, the growth of the strain was increased to 9.5 log cfu / mL after 48 hours at the initial level of about 5.4 log cfu / mL. (Table 8). The growth of the strain was increased to 9.5 log cfu / mL after 48 hours at the initial level of about 5.6 log cfu / mL. The growth rate of the strain was higher than that of the safflower seed oil (Table 9).
도 6a ~ 도 6h에서 확인할 수 있듯이, 콩 제품에서 CLA 함유량은 홍화씨유의 첨가량이 증가할수록 농도 의존적으로 증가하였다. 구체적으로 살펴보면, 락토바실러스 플란타륨 S48 균주의 경우는 홍화씨 기름 1.0% 첨가 대풍콩 가수분해물을 사용한 콩 제품에서 가장 높은 CLA 함유량 (cis-9, trans-11는 77.66 μg/ml 및 trans-10,cis-12는 57.71 μg/ml)를 나타냈고 (도 6a ~ 6d), 락토바실러스 플란타륨 P1201 균주의 경우도 홍화씨 기름 1.0% 첨가 대풍콩 가수분해물을 사용한 콩 제품에서 가장 높은 CLA 함유량 (cis-9, trans-11는 89.97 μg/ml 및 trans-10, cis-12는 68.78 μg/ml)를 나타냈다(도 6e ~ 6h).
As can be seen from Figs. 6a to 6h, the content of CLA in soybean products increased in a concentration-dependent manner as the amount of safflower seed oil was increased. In the case of Lactobacillus plantarum S48 strain, the highest CLA content ( cis- 9, trans- 11, 77.66 μg / ml and trans- 10, cis -12 is showed a 57.71 μg / ml) (Fig. 6a ~ 6d), Lactobacillus Planta volume if the strain P1201 is also the highest CLA content in safflower oil, soy products with added 1.0% soy hydrolyzate Dafeng (cis - 9, 89.97 μg / ml for trans- 11 and 68.78 μg / ml for trans- 10 and cis- 12) (Figs. 6e to 6h).
Claims (14)
250 ~ 1000 μg/ml의 리놀레산 농도에서 44.97 ~ 93.66 μg/ml의 공액리놀레산의 생산성을 갖고 그리고 증진된 내산성 및 내담즙산성을 갖는 것을 특징으로 하는 균주.
Lactobacillus plantarum S48 strain deposited with accession number KACC91849P,
A productivity of conjugated linoleic acid of 44.97 to 93.66 μg / ml at a linolenic acid concentration of 250 to 1000 μg / ml, and having enhanced acidity and bile bile acidity.
250 ~ 1000 μg/ml의 리놀레산 농도에서 44.97 ~ 93.66 μg/ml의 공액리놀레산의 생산성을 갖고 그리고 증진된 내산성 및 내담즙산성을 갖는 것을 특징으로 하는 균주.
Lactobacillus plantarum P1201 deposited with accession number KACC91848P,
A productivity of conjugated linoleic acid of 44.97 to 93.66 μg / ml at a linolenic acid concentration of 250 to 1000 μg / ml, and having enhanced acidity and bile bile acidity.
A probiotics comprising the strain according to claim 1 or 2 or a culture thereof as an active ingredient.
The active agent according to claim 3, wherein the active agent is in the form of a dried cell or a fermented composition.
A food having increased conjugated linoleic acid content comprising the strain according to any one of claims 1 or 2 or a culture thereof.
The food according to claim 5, wherein the food is any one selected from the group consisting of soybean products, dairy products, fermented milk, fermented foods and fermented beverages.
제 1항 또는 제 2항에 따른 균주를 식품 재료에 첨가하여 20 ~ 40 ℃ 에서 12 시간이상 발효시키는 단계를 포함하고,
발효 전에, 식품의 재료에 셀룰라제, 프로테아제 및 에스테라제로 구성되는 군에서 선택되는 하나 이상의 효소를 처리하는 단계를 추가로 포함하는 것인 제조방법.
A method for producing a food having an increased conjugated linoleic acid content,
Adding a strain according to claim 1 or 2 to a food material and fermenting the mixture at 20 to 40 DEG C for at least 12 hours,
Further comprising, prior to fermentation, treating the food material with at least one enzyme selected from the group consisting of cellulase, protease and esterase.
The method according to claim 7, wherein before fermentation, at least one vegetable oil selected from the group consisting of safflower seed oil, evening primrose oil, and Gucci mulberry seed oil is added.
A food having an increased content of conjugated linoleic acid produced by the method according to claim 7.
콩을 수침한 후 분쇄하여 콩 분쇄액을 제조하고,
콩 분쇄액을 증자처리하고,
증자된 콩 분쇄액에 셀룰라제, 프로테아제 및 에스테라제로 구성되는 군으로부터 선택되는 1종 이상의 효소를 1 ~ 10 unit씩 처리하여 콩 가수분해물을 제조하고,
콩 가수분해물에 제 1항 또는 제 2항에 따른 균주를 접종하여 20 ~ 40 ℃에서 12시간 이상 발효시키는 것으로 이루어지는 제조방법.
A method for producing a soybean product having an increased conjugated linoleic acid content,
The soybean was soaked and pulverized to prepare a bean pulverized liquid,
The soybean pulverizing solution was subjected to a thickening treatment,
1 to 10 units of at least one enzyme selected from the group consisting of cellulase, protease and esterase is added to the soybean pulverized liquid to prepare soybean hydrolyzate,
Which comprises fermenting soybean hydrolyzate at 20 to 40 DEG C for at least 12 hours by inoculating the strain according to claim 1 or 2.
12. The method according to claim 11, wherein, after the thickening treatment, at least one vegetable oil selected from the group consisting of safflower seed oil, evening primrose oil, and Gucci mackerel oil is added.
A soybean product having an increased content of conjugated linoleic acid produced by the method according to claim 11.
14. The soybean product according to claim 13, wherein the soybean product is processed into any one form selected from the group consisting of soybean milk, tofu, soybean meat, soybean snack, and soybean paste.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130138053A KR101544180B1 (en) | 2013-11-14 | 2013-11-14 | Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130138053A KR101544180B1 (en) | 2013-11-14 | 2013-11-14 | Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150055729A KR20150055729A (en) | 2015-05-22 |
KR101544180B1 true KR101544180B1 (en) | 2015-08-12 |
Family
ID=53391215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130138053A KR101544180B1 (en) | 2013-11-14 | 2013-11-14 | Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101544180B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105794995B (en) * | 2016-04-06 | 2019-08-30 | 江苏省农业科学院 | The technique of lactobacillus-fermented yellow serofluid preparation wintercherry bean curd |
KR102392529B1 (en) * | 2019-06-27 | 2022-04-29 | 서울대학교산학협력단 | Feed assifive for fowl comprising linseed and Lactobacillus plantarum sp.as an efficient component and preparation method of the same |
-
2013
- 2013-11-14 KR KR1020130138053A patent/KR101544180B1/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
Ann. Microbiol., Vol.62, pp.1311-1320(Epub.2011.11.16.) |
Journal of Food Science, Vol.77, pp.M330-M336(Epub.2012.05.16.)* |
Also Published As
Publication number | Publication date |
---|---|
KR20150055729A (en) | 2015-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100747754B1 (en) | Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread | |
Lee et al. | Functional properties of Lactobacillus strains isolated from kimchi | |
KR101500974B1 (en) | Lactobacillus plantarum HAC01 having anti-inflammation and metabolic disease improvement effect and uses thereof | |
Liu et al. | Production of conjugated linoleic acids by Lactobacillus plantarum strains isolated from naturally fermented Chinese pickles | |
Thwe et al. | Isolation, characterization, and utilization of γ-aminobutyric acid (GABA)-producing lactic acid bacteria from Myanmar fishery products fermented with boiled rice | |
KR20130113036A (en) | Novel bacillus subtilis | |
KR101700625B1 (en) | Pediococcus pentosaceus KCC-23 and composition comprising the same | |
KR101834231B1 (en) | Vegetable Lactobacillus plantarum DSR KF15 having Activities on Antimicrobial And Antifungal for keeping freshness and Use Thereof | |
Uugantsetseg et al. | Antioxidant activity of probiotic lactic acid bacteria isolated from Mongolian airag | |
KR101566989B1 (en) | Lactic acid bacterium having activity of lowering blood cholesterol level separated from kimchii and uses thereof | |
KR101544180B1 (en) | Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains | |
Miranda-Yuquilema et al. | Obtaining, characterization and evaluation of two candidate preparations for probiotics developed with agroindustrial waste | |
JP6230050B2 (en) | Lactic acid bacteria with gastrointestinal mucosa adhesion | |
KR101696670B1 (en) | Lactobacillus plantarum llp5193 having high resistance ability of acid and bile and high cell adhesion ability, and product comprising it as effective factor | |
KR101919764B1 (en) | Bacillus subtilis hd 9098, probiotics composition including the same and method of manufacturing thereof | |
KR101995705B1 (en) | A conjugated linoleic acid production method from linoleic acid by combination of Bifidobacterium breve LDTM8001(KCTC 18423P) and Bifidobacterium breve LDTM 8002(KCTC 18424P) | |
KR20230158695A (en) | Method of producing B.clausii and alkaline protease by using solid-state fermentation and thereof feed additives | |
KR101673055B1 (en) | Novel starter strain and method functional fermentation foods containing bean curd use thereof | |
Seo et al. | Identification of potential Bacillus subtilis probiotics from Korean soybean paste and their antimicrobial and immune activities | |
KR20180060767A (en) | Novel Lactobacillus sakei CH1 and fermented food using the same | |
KR100725012B1 (en) | The new lactobacillus acidophilus HY 7036 isolated from korean adult, having high constipation improvement effect, high relieving intestinal disorders and high organic acid producibility, and products containing it | |
KR101101894B1 (en) | Strains of lactobacillus fermentum lc272 having the production ability of vitamin k2 | |
KR101726207B1 (en) | --glucosidase LT19-2 [KCTC18497P]Novel Bifidobacterium animalis LT19-2 strain[KCTC18497P] having excellent -glucosidase activity | |
KR20150088588A (en) | Novel Gamma-Amino Butyric Acid Producing Strain of Lactobacillus Brevis CFM11 and Use of the Same | |
EP4011216A1 (en) | Bifidobacterium having low activity of inducing generation of inflammatory cytokines and high activity of inducing generation of anti-inflammatory cytokines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |